RESEARCHER PROFILE

Catrin Lutz

← Back to Oncode Institute

C

Oncode Institute

Fibroblast Growth Factor ResearchCancer Cells and MetastasisBreast Cancer Treatment StudiesCancer Genomics and DiagnosticsTGF-β signaling in diseases

Catrin Lutz works in Fibroblast Growth Factor Research, Cancer Cells and Metastasis, Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, TGF-β signaling in diseases. Recorded institutional associations include The Netherlands Cancer Institute, Oncode Institute.

89Publications
810Citations
12H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells

    2018 · 155 citations
  2. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

    2022 · 144 citations
  3. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

    2022 · 121 citations
  4. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

    2019 · 70 citations
  5. In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer

    2020 · 60 citations
  6. Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers

    2023 · 47 citations
  7. The Diagnostic Accuracy of Methylation Markers in Urine for The Detection of Bladder Cancer: A Systematic Review

    2018 · 37 citations
  8. A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression

    2023 · 34 citations
  9. Mechanisms that clear mutations drive field cancerization in mammary tissue

    2024 · 31 citations
  10. Luminal breast cancer identity is determined by loss of glucocorticoid receptor activity

    2023 · 25 citations
  11. Rat Models of Hormone Receptor-Positive Breast Cancer

    2024 · 22 citations
  12. Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

    2022 · 16 citations
  13. Fasting boosts breast cancer therapy efficacy via glucocorticoid activation

    2025 · 11 citations
  14. Emerging roles of cohesin-STAG2 in cancer

    2024 · 10 citations
  15. MYC promotes immune-suppression in TNBC via inhibition of IFN signaling

    2021 · 9 citations
  16. Large-scale Characterization of Orthotopic Cell Line–Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness

    2025 · 6 citations
  17. The complex landscape of luminal breast cancer

    2024 · 5 citations
  18. The C-Terminal Kinase Domain–Binding and Suppression Motif Prevents Constitutive Activation of FGFR2

    2025 · 2 citations
  19. C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3

    2025 · 2 citations
  20. Abstract IA012: Mammary epithelial architecture modulates field cancerization

    2022 · 1 citations
  21. Abstract PR003: Pioneering genetic rat models of Ductal Carcinoma in situ (DCIS)

    2022 · 1 citations
  22. Abstract LB_B04: Deciphering FGFR3-TACC3 oncogenic fusions

    2023 · 1 citations
  23. Abstract A01: Somatic engineering of the mammary gland for the development of novel mouse models of triple-negative breast cancer

    2018 · 0 citations
  24. Abstract 5115: Establishing tumoroid and mouse models for functional validation of progression markers in DCIS

    2018 · 0 citations
  25. Abstract B37: Understanding DCIS initiation and progression using PDX and genetically engineered mouse and rat models

    2020 · 0 citations

← Return to the university profile